Speciality Medicines Ltd
LOT Size 2,000
SPML - Swing Trade Watch
SPML is showing signs of consolidation after a sharp correction. The stock is trading near key support zone while the falling trendline indicates a possible breakout setup.
A decisive breakout above the descending trendline, supported by strong volumes, could trigger the next leg of the move.
Trade Setup
📌 CMP: ₹201
✅ Watch for a breakout with strong volume confirmation.
Best Buy near 182
🛑 Stop Loss: Below ₹172 (Closing Basis)
🎯 Potential Targets:
• ₹230
• ₹255
• ₹280
Expecting move till 330 odd
Fundamental View
The company has reported improving business performance in recent financial periods, and investors should continue tracking revenue growth, profitability and execution in the coming quarters.
Things to Watch
As a relatively new listed company, there is limited long-term financial history available.
Monitor quarterly revenue growth, margins and promoter shareholding trends before taking larger allocations.
This is a watchlist trade, not an aggressive buy. Wait for a confirmed breakout before initiating fresh positions.
Please Note:
SME investing can deliver exceptional returns,
but the downside can be equally severe.
Always respect the mentioned
Stop Loss and Trail Stop Loss (TSL).
Disclosure: The Research Analyst and/or clients may have positions in the security discussed. Views are based on technical and fundamental analysis and are subject to change without prior notice.
LOT Size 2,000
SPML - Swing Trade Watch
SPML is showing signs of consolidation after a sharp correction. The stock is trading near key support zone while the falling trendline indicates a possible breakout setup.
A decisive breakout above the descending trendline, supported by strong volumes, could trigger the next leg of the move.
Trade Setup
📌 CMP: ₹201
✅ Watch for a breakout with strong volume confirmation.
Best Buy near 182
🛑 Stop Loss: Below ₹172 (Closing Basis)
🎯 Potential Targets:
• ₹230
• ₹255
• ₹280
Expecting move till 330 odd
Fundamental View
The company has reported improving business performance in recent financial periods, and investors should continue tracking revenue growth, profitability and execution in the coming quarters.
Things to Watch
As a relatively new listed company, there is limited long-term financial history available.
Monitor quarterly revenue growth, margins and promoter shareholding trends before taking larger allocations.
This is a watchlist trade, not an aggressive buy. Wait for a confirmed breakout before initiating fresh positions.
Please Note:
SME investing can deliver exceptional returns,
but the downside can be equally severe.
Always respect the mentioned
Stop Loss and Trail Stop Loss (TSL).
Disclosure: The Research Analyst and/or clients may have positions in the security discussed. Views are based on technical and fundamental analysis and are subject to change without prior notice.
Trade ist aktiv
Pls note Lot size is 1K not 2
Website:
nareshg.in
Telegram:
t.me/NareshGSebiRegistered
YouTube:
youtube.com/@NareshGSebiRA
Best Regards
Naresh G
SEBI Registered Research Analyst
INH000010797
nareshg.in
Telegram:
t.me/NareshGSebiRegistered
YouTube:
youtube.com/@NareshGSebiRA
Best Regards
Naresh G
SEBI Registered Research Analyst
INH000010797
Verbundene Veröffentlichungen
Haftungsausschluss
Die Informationen und Veröffentlichungen sind nicht als Finanz-, Anlage-, Handels- oder andere Arten von Ratschlägen oder Empfehlungen gedacht, die von TradingView bereitgestellt oder gebilligt werden, und stellen diese nicht dar. Lesen Sie mehr in den Nutzungsbedingungen.
Website:
nareshg.in
Telegram:
t.me/NareshGSebiRegistered
YouTube:
youtube.com/@NareshGSebiRA
Best Regards
Naresh G
SEBI Registered Research Analyst
INH000010797
nareshg.in
Telegram:
t.me/NareshGSebiRegistered
YouTube:
youtube.com/@NareshGSebiRA
Best Regards
Naresh G
SEBI Registered Research Analyst
INH000010797
Verbundene Veröffentlichungen
Haftungsausschluss
Die Informationen und Veröffentlichungen sind nicht als Finanz-, Anlage-, Handels- oder andere Arten von Ratschlägen oder Empfehlungen gedacht, die von TradingView bereitgestellt oder gebilligt werden, und stellen diese nicht dar. Lesen Sie mehr in den Nutzungsbedingungen.